- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05241483
Remote Patient Monitoring and Detection of Possible Diseases With Artificial Intelligence Telemedicine System (AI - diseases)
March 3, 2022 updated by: Sezgin SEZER, Setint AI Robotic Sistem Egitim ve Danısmanlık San. Tic. A.S.
SETİNT AI-Diseases
Remote patient monitoring and detection of possible diseases with Artificial Intelligence Telemedicine System
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Possible disease detection with artificial intelligence from the patient's vital values possible disease detection from the patient's examination records
Study Type
Observational
Enrollment (Anticipated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sezgin SEZER
- Phone Number: +905374393466
- Email: setint@outlook.com
Study Contact Backup
- Name: Olgar ATASEVEN
- Phone Number: +905367906777
- Email: olgar.ataseven@gmail.com
Study Locations
-
-
-
Düzce, Turkey, 81620
- Recruiting
- Setint Ai
-
Contact:
- Sezgin SEZER
- Phone Number: +905374393466
- Email: setint@outlook.com
-
Contact:
- Email: setintrd@gmail.com
-
Principal Investigator:
- Sezgin SEZER
-
Sub-Investigator:
- Olgar ATASEVEN
-
Sub-Investigator:
- Aykut COŞKUN, MD
-
Sub-Investigator:
- İsmail ÇELİK, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients registered in the SETINT AI artificial intelligence Telemedicine system
Description
Inclusion Criteria:
- No Eligibility Criteria
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
fever
Remote patient monitoring.
fever values recorded by the patient in the system.
Validation of pre-diagnosis results of AI systems to detect fever-related diseases.
|
Possible diseases that may occur as a result of the patient's vital values with artificial intelligence systems
Other Names:
|
|
pulse
Remote patient monitoring.
pulse values recorded by the patient in the system.
Validation of pre-diagnosis results of AI systems to detect fever-related diseases.
|
Possible diseases that may occur as a result of the patient's vital values with artificial intelligence systems
Other Names:
|
|
blood pressure
Remote patient monitoring.
Blood pressure values recorded by the patient in the system.
Validation of pre-diagnosis results of AI systems to detect fever-related diseases.
|
Possible diseases that may occur as a result of the patient's vital values with artificial intelligence systems
Other Names:
|
|
oxygen saturation
Remote patient monitoring.
oxygen saturationvalues recorded by the patient in the system.
Validation of pre-diagnosis results of AI systems to detect fever-related diseases.
|
Possible diseases that may occur as a result of the patient's vital values with artificial intelligence systems
Other Names:
|
|
glucose
Remote patient monitoring.
glucose values recorded by the patient in the system.
Validation of pre-diagnosis results of AI systems to detect fever-related diseases.
|
Possible diseases that may occur as a result of the patient's vital values with artificial intelligence systems
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient symptoms and disease confirmation
Time Frame: May - October 2021
|
Her physician's patient symptom data were successfully matched to ICD-10 and other disease codes using the AI model.
|
May - October 2021
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Aykut COŞKUN, MD, SETINT AI Robotic Sistem Eğitim ve Danışmanlık San.Tic.A.Ş.
- Principal Investigator: İsmail ÇELİK, MD, SETINT AI Robotic Sistem Eğitim ve Danışmanlık San.Tic.A.Ş.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 30, 2020
Primary Completion (ACTUAL)
July 20, 2021
Study Completion (ANTICIPATED)
December 30, 2022
Study Registration Dates
First Submitted
February 3, 2022
First Submitted That Met QC Criteria
February 5, 2022
First Posted (ACTUAL)
February 15, 2022
Study Record Updates
Last Update Posted (ACTUAL)
March 7, 2022
Last Update Submitted That Met QC Criteria
March 3, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- SETİNT-AI-TURKEY
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Predictive Value of Tests
-
Erebouni Medical CenterFisher and Paykel HealthcareRecruitingPredictive Value of TestsArmenia
-
Medical University of SilesiaCompletedPredictive Value of Tests | IntubationPoland
-
National and Kapodistrian University of AthensCompletedAnatomic Features of the Neck and Preoperative Tests as Predictive Markers of Difficult LaryngoscopyAirway Management | Predictive Value of Tests
-
Medical University of SilesiaCompletedPredictive Value of Tests | Intubation;DifficultPoland
-
Medical University of SilesiaCompletedAirway Management | Predictive Value of TestsPoland
-
Paolo Pastori, MDUniversity Hospital of Ferrara; Azienda Unita Sanitaria Locale Reggio Emilia; Azienda Unita Sanitaria Locale di PiacenzaRecruitingPredictive Value of Tests | Defibrillators, Implantable | Pacemaker, Artificial | Electrodes, ImplantedItaly
-
Ottawa Hospital Research InstituteCompletedFrail Elderly Syndrome | Surgery | Predictive Value of Tests | Outcomes
-
Medical University of SilesiaUnknownObesity | Predictive Value of Tests | Intubation, IntratrachealPoland
-
Peking University First HospitalCompletedBreast Cancer | Predictive Value of Tests | Neoadjuvant Therapy | Prognosis | HER2 | Neoplasm Staging | Estrogen Receptor | Histological GradeChina
-
Torben PottgiesserRecruitingCardiovascular Diseases | Thrombosis | Aortic Valve Stenosis | Transcatheter Aortic Valve Replacement | Predictive Value of Tests | Thrombelastography | Platelet Function TestsGermany
Clinical Trials on mesure valition
-
Centre Hospitalier Universitaire de NiceUnknown
-
Pierre Fabre Dermo CosmetiqueCompletedHealthy | Rosacea | Seborrheic Dermatitis | Atopic Dermatitis | Psoriasis Vulgaris | AcneFrance
-
Centre Hospitalier Universitaire, AmiensCompleted
-
University Hospital, LilleCompletedValgus Foot DeformityFrance
-
Rennes University HospitalCompleted